Drugs Market Research Reports & Industry Analysis

... , such as specimen preparation devices, controls, calibrators and others. Future Horizons and Growth Strategies in the Global Drugs of Abuse Testing Market 2015” is a unique ...

... as specimen preparation devices, controls, calibrators and others. Future Horizons and Growth Strategies in the European Therapeutic Drug Monitoring (TDM) Market 2015: Supplier ...

... , such as specimen preparation devices, controls, calibrators and others. Future Horizons and Growth Strategies in the Global Therapeutic Drug Monitoring (TDM) Market 2015 ...

... in the near future. Atorvastatin, a common drug that can lower blood cholesterol levels, was developed by Pfizer under the trade name of Lipitor. Boasting of nearly ... miracle among all the medicines for sale. After entering China, atorvastatin develops fast with annual sales value rising from less ...

... Tacrolimus (also FK506) is a macrolide lactone immunosuppressive drug discovered from a soil sample that contained the bacterium Streptomyces tsukubaensis in 1984 by Fujisawa Pharmaceutical Co., Ltd. Tacrolimus ...

... : market size of insulin lispro in China market share of manufacturers of Insulin Lispro in China retail price of insulin lispro in Chinese market major manufacturers of insulin lispro in Chinese market market outlook of insulin lispro in China The author suggests ...

... name of Xeloda and then spread through over 80 countries and regions in 2 years. In Mar. 2001, capecitabine entered China to be clinically used for the treatment of advanced breast cancer, colorectal cancer and other solid tumors. The chemotherapy for colorectal cancer ...

... the market. In Sep. 2000, celebrex (celecoxib capsule) made by Pfizer Inc was approved by CFDA to enter China. Celecoxib develops fast then, ... celecoxib in Chinese market market outlook of celecoxib in China The author suggests the following groups of people purchase this report: manufacturers of NSAIDs ...

... desloratadine in China market share of manufacturers of desloratadine in China price of desloratadine in Chinese market major manufacturers of desloratadine in Chinese market market outlook of desloratadine in China ...

... doxofylline in China market share of manufacturers of doxofylline in China price of doxofylline in Chinese market major manufacturers of doxofylline in Chinese market market outlook of doxofylline in China ...

... Cerebrovascular disease is one of the three principal diseases that can cause people to death. Acute cerebral infarction which occupies 70% of cerebrovascular disease ...

... estimate of the incidence of hyperlipemia is 7%-8% while the actual incidence might be above 10%. Over 100 million people in China have to receive ... this report: market size of ezetimibe in China price of ezetimibe in Chinese market market outlook of ezetimibe in China The author suggests the following groups ...

... diabetes incidence in China. Liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, was developed by Novo Nordisk in 2008 to treat diabetes. Liraglutide, a derivative attained by attaching a fatty acid molecule to GLP-1 molecule, can reduce the HbA1c level and weight of type 2 diabetes ...

... varieties of steroid’s APIs, half are made in China. As a variety performing well in hospitals in recent years, methylprednisolone, ... methylprednisolone entered China in the late 1990s under the trade names of Medrol (Pfizer) and Solu-Medrol (Pharmacia & Upjohn). The APIs and preparations of methylprednisolone ...

... octreotide in China market share of manufacturers of octreotide in China price of octreotide in Chinese market major manufacturers of octreotide in Chinese market market outlook of octreotide in China ...

... and treatment of hemophilia have a huge market. Apart from Bayer Schering, Baxter and Wyeth also make recombinant factor Ⅷ too. After entering China, recombinant factor Ⅷ develops ... report: sales status of recombinant factor Ⅷ in China price of recombinant factor Ⅷ in Chinese market major manufacturers of recombinant factor Ⅷ in Chinese market share of dosage forms of recombinant factor Ⅷ in China market outlook of recombinant factor Ⅷ in China The author suggests ...

... tiotropium bromide in Chinese hospitals price of tiotropium bromide in Chinese hospitals major manufacturers of tiotropium bromide in Chinese market share of different dosage forms of tiotropium bromide in Chinese hospitals market outlook of tiotropium bromide in China ...

... hypertension is a controllable disease. In 1991, olmesartan medoxomil was successfully developed by Sankyo Pharmaceuticals Co., Ltd and was patented in many countries. In Apr. 2002, olmesartan medoxomil ... ARBs, olmesartan medoxomil has distinctive pharmacokinetic properties. It develops fast after entering China ...

... Imatinib Mesylate in China major manufacturers of Imatinib Mesylate in the Chinese market and their market share retail price of Imatinib Mesylate in China market outlook of Imatinib Mesylate in China ...

... insulin detemir in Chinese market price of insulin detemir in Chinese market major manufacturers of insulin detemir in China share of different dosage forms of insulin detemir in Chinese market market outlook of insulin detemir in China ...

... Linezolid, a synthetic oxazolidinone, was developed by Pharmacia & Upjohn. In 2000, it was approved by FDA to be used for infection caused by gram-positive ... China, linezolid market has long been monopolized by foreign pharmaceutical corporations. Since the patent for linezolid ...

... meropenam is one of the few broad-spectrum antibiotics that can treat various infectious diseases. Therefore, meropenam will remain the main antibiotic ...

... under the trade names of Macmiror and Macmiror Complex. Nifuratel develops fast after entering China with annual sales rising ... of nifuratel in Chinese market market outlook of nifuratel in China The author suggests the following groups of people purchase this report: manufacturers of gynecological ...

... Senile dementia poses a serious threat to old people. According to statistics, about 10% of people aged above 60 suffer from senile dementia, among which 5% have Alzheimei’s Disease (AD). In China, the number of senile dementia ...

... market share compared with other cardiovascular drugs. According to CRI’s survey, phosphocreatine develops fast after entering China with annual sales value rising ... of phosphocreatine in Chinese market market outlook of phosphocreatine in China The author suggests the following groups of people purchase this report: manufacturers of drugs for cardiovascular disease investors ...

... After rivaroxaban entering the Chinese market under the trade name of Xarelto in the latter ... rivaroxaban in Chinese hospitals price of rivaroxaban in Chinese hospitals major manufacturers of rivaroxaban share of different dosage forms of rivaroxaban in Chinese hospitals market outlook of rivaroxaban in China ...

... and prostate and reducing urethral pressure, but it can’t cure BPH. Compared with other α1-adrenergic receptor blockers, tamsulosin ... Boehringer Ingelheim. Prostate drug market is highly concentrated in China. Three kinds of prostate drugs – finasteride, tamsulosin and prostat which occupy over 90% of prostate ...

... Tegafur, gimeracil and oteracil (Tegafur/gimeracil/oteracil), a fluorouracil derivative, is an oral biological anti-cancer agent made up of tegafur (FT), gimeracil (CDHP) and oteracil ...

... HT3 receptor antagonist ondansetron under the trade name of Zofran, a bunch of derivatives have come out, including tropisetron made by Novartis under the trade name of Navoban. Tropisetron ...

... fungal infection take up over 60%. Voriconazole, a kind of triazole, was developed by Pfizer and came into the US market in 2002. In 2005, voriconazole was introduced into China ... rest Chinese market. According to CRI’s investigation, Voriconazole develops fast after entering China with annual sales rising from ...

... market access issues you need to understand and practically address? Commercial Excellence in Rare Diseases and Orphan Drugs is a highly-detailed report for industry management ... orphan drugs and the way in which rare disease teams should be structured in order to maximise commercial success Understand the regulatory structures that determine ...

The Global Probiotics Market is estimated to be $27.6 billion in 2014 and is expected to grow at a CAGR of 10.3% to reach $60.5 billion by 2022. The factors that are influencing the market growth include increase ... into Probiotic Functional Foods & Beverages, Probiotic Dietary Supplements and Animal Feed Probiotics. Based on end user, it can be segmented into Human Probiotics and Animal Probiotics. Global Probiotics Market ...

... name of Singulair. In 2000 and 2002, Montelukast chewable tablets (4mg) and Montelukast granules ... China Montelukast’s price in Chinese hospitals the production status of generic drugs of Montelukast in China major Montelukast manufacturers and their market share in China Market outlook of Montelukast in China ...

... insulin glargine in China market share of insulin glargine manufacturers in sample hospitals in China retail price of insulin glargine in Chinese market major manufacturers of insulin glargine in Chinese market market outlook of insulin glargine in China ...

... Rituximab in China Hospital Market Market Share of Rituximab by Dosage Form in China Hospital Market Incidence of Autoimmune Diseases in China Manufacturing Schedule of Rituximab Generic Drug Prospect of China Rituximab ...

... Esomeprazole (Nexium) in China Hospital Market Major Esomeprazole Manufacturers in China Patent Status of Esomeprazole in China Share of Esomeprazole in Different Dosage Forms in China Hospital Market Prospect of China Esomeprazole ...

... China formulates that the valid term for a patent is 20 years, therefore, Viagra’s patent shall expire in 2014. During the 20 years, Sildenafil (trade name Viagra ...

... -2014 was about 13.7%. Currently, Bayer’s products have taken up 70% of Acarbose market in China while and Sichuan Luye Bao Guang Pharmaceutical Industry Co., Ltd claim the ... size of Acarbose in China major manufacturers of Acarbose for Chinese market and their market share retail price of Acarose in Chinese market market outlook of Acarbose in China The ...

... valued. As clotrimazole is sold at a relatively low price, it grows fast despite a small market scale. Ever since its first entry into China, clotrimazole develops ... : market size of clotrimazole in China major manufacturers of clotrimazole in Chinese market and their market share retail price of clotrimazole in Chinese market market outlook of clotrimazole in China The author ...

... use hormone therapy. Common varieties of progestin are medroxyprogesterone and megestrol which act by blocking the source of human estrogen with an unsatisfactory ... size of megestrol in China major manufacturers of megestrol for Chinese market and their market share retail price of megestrol in Chinese market market outlook of megestrol in China The author ...

... market size of nicergoline in sample hospitals was about CNY 89 million in 2010 and CNY 76 million in 2014. In future years, China's nicergoline market will shrank ... price of nicergoline in hospital market in China Market Share of Major Nicergoline Manufacturers in China Patent Status of Nicergoline in China Market share of Nicergoline by dosage form in hospital market in China Prospect of China Nicergoline Market The ...

... -page report from VPGMarketResearch.com provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation ... as specimen preparation devices, controls, calibrators and others. 2014 Strategies for the European Drugs of Abuse Testing Market” is a unique study designed to help ...

... -page report from VPGMarketResearch.com provides a comprehensive analysis of the European therapeutic drug monitoring market, including emerging tests, technologies, instrumentation ... as specimen preparation devices, controls, calibrators and others. 2014 Strategies for the European Therapeutic Drug Monitoring (TDM) Market: Hospitals, Commercial Labs ...

... -page report from VPGMarketResearch.com provides a comprehensive analysis of the French drug of abuse testing market, including emerging tests, technologies, instrumentation ... as specimen preparation devices, controls, calibrators and others. 2014 Strategies for the French Drugs of Abuse Testing Market” is a unique study designed to help ...

... -page report from VPGMarketResearch.com provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation ... as specimen preparation devices, controls, calibrators and others. 2014 Strategies for the French Therapeutic Drug Monitoring (TDM) Market is a unique market and ...

... -page report from VPGMarketResearch.com provides a comprehensive analysis of the German drug of abuse testing market, including emerging tests, technologies, instrumentation ... as specimen preparation devices, controls, calibrators and others. 2014 Strategies for the German Drugs of Abuse Testing Market is a unique study designed to help ...

... -page report from VPGMarketResearch.com provides a comprehensive analysis of the German therapeutic drug monitoring market, including emerging tests, technologies, instrumentation ... as specimen preparation devices, controls, calibrators and others. 2014 Strategies for the German Therapeutic Drug Monitoring (TDM) Market” is a unique market and ...

... , such as specimen preparation devices, controls, calibrators and others. 2014 Strategies for the Global Drugs of Abuse Testing Market” is a unique study ...

... , such as specimen preparation devices, controls, calibrators and others. 2014 Strategies for the Global Therapeutic Drug Monitoring (TDM) Market is a unique ...

... -page report from VPGMarketResearch.com provides a comprehensive analysis of the Italian drug of abuse testing market, including emerging tests, technologies, instrumentation ... as specimen preparation devices, controls, calibrators and others. 2014 Strategies for the Italian Drugs of Abuse Testing Market is a unique study designed to help ...